{
    "code": "52026968",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026968",
    "time": "2016-12-16 03:22:50",
    "許可證字號": "衛部藥輸字第026968號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/11\/10",
    "發證日期": "105\/11\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202696807",
    "中文品名": "泰格莎膜衣錠80毫克",
    "英文品名": "TAGRISSO Film-coated Tablets 80 mg",
    "適應症": "適用於治療具有EGFR T790M基因突變之局部侵犯性或轉移性非小細胞肺癌(NSCLC)在EGFR TKI治療期間或之後惡化的患者。治療前須經衛福部核准方式檢測為EGFR T790M基因突變。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "Osimertinibmesylate"
    ],
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F420032000  ASTRAZENECA AB",
        "製造廠廠址": "S-151 85 SODERTALJE SWEDEN",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200082310",
            "成分名稱": "Osimertinib mesylate",
            "含量描述": "(1.192mg of osimertinib mesylate is equivalent to 1 mg of osimertinib freebase)",
            "含量": "95.4000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "026968-TAGRISSO 80 mg 中文仿單-105-11-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026968&Seq=001&Type=9"
        },
        {
            "title": "026968-TAGRISSO 80mg-鋁箔-105-11-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026968&Seq=002&Type=8"
        },
        {
            "title": "026968-TAGRISSO 80mg-外盒-105-11-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026968&Seq=001&Type=8"
        }
    ]
}